Group One Trading, L.P. Aptinyx Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.69 $1,200 - $6,899	-10,000 Reduced 32.62%	20,653 $2,000
Q4 2022 Feb 09, 2023	SELL	$0.23 - $0.34 $3,905 - $5,773	-16,981 Reduced 35.65%	30,653 $8,000
Q3 2022 Nov 09, 2022	SELL	$0.35 - $0.72 $8,257 - $16,987	-23,594 Reduced 33.12%	47,634 $18,000
Q2 2022 Aug 11, 2022	BUY	$0.38 - $2.58 $12,416 - $84,301	32,675 Added 84.75%	71,228 $40,000
Q1 2022 May 12, 2022	BUY	$2.27 - $3.62 $62,218 - $99,220	27,409 Added 245.95%	38,553 $88,000
Q4 2021 Feb 11, 2022	BUY	$2.11 - $3.0 $23,513 - $33,432	11,144 New	11,144 $30,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.